(Q39148402)

9 September 2017

title

Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cells (English)

1 reference

9 September 2017

1 reference

Huaping Liu

1

1 reference

9 September 2017

Metin Kurtoglu

2

1 reference

9 September 2017

Yenong Cao

3

1 reference

9 September 2017

Haibin Xi

4

1 reference

9 September 2017

Rakesh Kumar

5

1 reference

9 September 2017

Jeffrey M Axten

6

1 reference

9 September 2017

Theodore J Lampidis

7

1 reference

9 September 2017

publication date

23 May 2013

1 reference

Cancer Chemotherapy and Pharmacology

9 September 2017

published in

1 reference

9 September 2017

volume

72

1 reference

9 September 2017

issue

1

1 reference

9 September 2017

page(s)

251-262

1 reference

https://scigraph.springernature.com/pub.10.1007/s00280-013-2193-y

9 September 2017

exact match

0 references

cites work

Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Targeting hypoxia, a novel treatment for advanced retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-d-glucose in tumor cells treated under hypoxic vs aerobic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

ER stress and the unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Protein glucosylation and its role in protein folding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Perk is essential for translational regulation and cell survival during the unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

PERK mediates cell-cycle exit during the mammalian unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Translation attenuation by PERK balances ER glycoprotein synthesis with lipid-linked oligosaccharide flux

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

On the Origin of Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Stable isotope-assisted metabolomics in cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Cytotoxicity of glucose analogues in V79 multicell spheroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

High endoplasmic reticulum activity renders multiple myeloma cells hypersensitive to mitochondrial inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Inhibition of Glycosylation of Viral Glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Coping with stress: eIF2 kinases and translational control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Phosphorylation of eIF2α at serine 51 is an important determinant of cell survival and adaptation to glucose deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

2-deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

Metabolic control of resistance of human epithelial cells to H2O2 and NO stresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2193-Y

10.1007/S00280-013-2193-Y

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference